文献速递头颈部肿瘤放疗

头颈癌选择性颈部照射剂量降至40Gy后的复发模式

Recurrence patterns after a decreased dose of 40Gy to the elective treated neck in head and neck cancer.
PubMed 文献 · Radiother Oncol · 2017-03-22

PURPOSE: To investigate the patterns of regional recurrences with emphasis on recurrences in the electively irradiated lymph node regions after dose de-escalation to 40Gy (EQD2Gy) in head and neck cancer.…

要点

  • 择区淋巴结40Gy后2年该区域复发率为3.9%(95%CI 1.8-6.0)。
  • 28例区域复发中9例位于择区照射区,5例在靶区外。
  • 择区照射区复发与年龄、性别、肿瘤部位、分期或HPV状态无关。

核心结论

  • 择区淋巴结照射40Gy后2年该区域复发率为3.9%(95%CI 1.8-6.0),与标准50Gy后的复发率相当。

主要发现

  • 2年总生存率为71.2%(95%CI 65.3-77.1),疾病特异性生存率为64.2%(95%CI 59.2-69.3)。
  • 2年局部、区域和远处控制率分别为84.1%(95%CI 79.1-89.2)、89.2%(95%CI 84.3-94.1)和83.2%(95%CI 76.3-90.1)。
  • 28例患者出现区域复发,其中14例在高剂量体积内,9例在择区照射淋巴结区域,5例在靶区外。
  • 择区照射淋巴结区域的2年实际复发率为3.9%(95%CI 1.8-6.0)。
  • 择区照射淋巴结区域复发与年龄、性别、肿瘤部位、分期或口咽癌HPV状态无显著关联。

临床怎么用

  • 头颈癌择区颈部照射采用40Gy(EQD2Gy)未增加区域复发,可作为降低剂量的参考依据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To investigate the patterns of regional recurrences with emphasis on recurrences in the electively irradiated lymph node regions after dose de-escalation to 40Gy (EQD2Gy) in head and neck cancer. METHODS AND MATERIALS: Two hundred thirty-three patients treated with radio(chemo)therapy using 40Gy (EQD2Gy) to the elective lymph node regions were included. All regional recurrences were reconstructed and projected on the initial radiotherapy planning Computed Tomography studies to identify the localization of recurrence. Furthermore, patient and treatment characteristics were correlated with the regional recurrences to identify risk factors. RESULTS: The median follow-up in our study was 26months. Overall- and disease-specific survival at 2years were 71.2% (95% CI 65.3-77.1) and 64.2% (95% CI 59.2-69.3), respectively. Local, regional and distant control at 2years was 84.1% (95% CI 79.1-89.2), 89.2% (95% CI 84.3-94.1) and 83.2% (95% CI 76.3-90.1), respectively. Twenty-eight patients experienced a regional recurrence. Fourteen of these patients had a recurrence within the high dose volume (14 of 28). Nine had a recurrence in the electively irradiated lymph node regions (9 of 28) and 5 recurrences occurred outside the target volume. The actuarial rate of recurrence in the electively irradiated lymph node regions was 3.9% (95% CI 1.8-6.0) at 2years. No significant associations could be observed between recurrence in electively irradiated lymph node regions and age, gender, tumor site, stage, or the presence of human papillomavirus in oropharyngeal cancers. CONCLUSIONS: The actuarial rate of recurrence in the electively irradiated lymph node regions was 3.9% (95% CI 1.8-6.0) at 2years. This incidence is comparable to recurrence rates after standard dose of 50Gy, suggesting that lower doses to the elective neck do not result in higher regional recurrences.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Nevens D, Duprez F, Daisne JF, et al. Recurrence patterns after a decreased dose of 40Gy to the elective treated neck in head and neck cancer. Radiother Oncol. 2017. PMID: 28342647. doi:10.1016/j.radonc.2017.03.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。